Sawhney Amarpreet 4
4 · OCULAR THERAPEUTIX, INC · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Sawhney Amarpreet
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-01-02+200,000→ 200,000 totalExercise: $4.10Exp: 2029-01-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.